Taysha Gene Therapies, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TSHA Nasdaq 2830 www.tayshagtx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Taysha Gene Therapies, Inc.

Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting - Jun 25th, 2026 2:01 pm
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - Jun 24th, 2026 8:33 pm
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - Jun 24th, 2026 2:01 pm
Taysha Advances Rett Syndrome Programme as Pivotal Trial Enrollment Completes (TSHA) - Jun 22nd, 2026 6:56 am
Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome - Jun 22nd, 2026 6:00 am
Taysha Gene Therapies (TSHA) Stock Looks Undervalued After Sharp Three Year Recovery - Jun 13th, 2026 6:12 am
Is Taysha Gene Therapies, Inc. (TSHA) A Good Stock To Buy Now? - Jun 11th, 2026 12:00 pm
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Jun 5th, 2026 6:01 am
Taysha Gene Therapies (TSHA) Reports Financial Results for Q1 2026 - May 14th, 2026 10:51 am
Canaccord Keeps Buy Rating on Taysha (TSHA) After Q1 Highlights - May 11th, 2026 3:21 pm
Assessing Taysha Gene Therapies (TSHA) Valuation After Strong Momentum And Recent Volatility - May 9th, 2026 4:16 pm
Taysha Gene Therapies, Inc. Q1 2026 Earnings Call Summary - May 7th, 2026 6:30 am
Taysha Gene Therapies Q1 Earnings Call Highlights - May 7th, 2026 1:24 am
Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update - May 6th, 2026 6:00 am
Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6 - Apr 29th, 2026 6:00 am
Has Taysha Gene Therapies (TSHA) Run Too Far After A 259% One Year Surge? - Apr 28th, 2026 12:06 am
Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting - Apr 27th, 2026 3:21 pm
Taysha Gene Therapies (TSHA) Stock Price Surges 343.45% From Year Ago Levels - Apr 22nd, 2026 8:25 am
This is Why Taysha Gene Therapies, Inc. (TSHA) is one of the Best Healthcare Penny Stocks to Buy - Apr 14th, 2026 3:50 am
Taysha Gene Therapies (TSHA) Making Progress on Crucial Rett Syndrome Treatment - Apr 6th, 2026 3:25 pm